North America Plasma Protein Therapeutics Market by product type (Immunoglobulins, Albumin, Coagulation Factors, alpha-1 proteinase inhibitor and others) by application (Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency and others) and by region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

North America Plasma Protein Therapeutics Market by product type (Immunoglobulins, Albumin, Coagulation Factors, alpha-1 proteinase inhibitor and others) by application (Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency and others) and by region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 236 | Pages: 135 | December 2016 | Region: North America


The North America Plasma Protein Therapeutics Market is currently valued to be $7.87 Billion market in 2015 held the most dominant share in global market and is estimated to reach $11.1 billion by the end of 2020 with a growth rate of 7.1%. Recent years have witnessed the increased usage of plasma proteins in medical applications. The advancements in technology has made the process for fractionating the protein from plasma more efficient and cost saving and is a huge boost to the market. Reports from suggest that half of the global blood donors are from high income countries which constitutes only 18% of the global population. Rising awareness among individuals regarding the significance of blood donations and government initiatives helped the market to propel the market at a significant rate.

Plasma, which is a protein rich fluid plays a critical role in clotting and providing immunity to diseases. Isolating these proteins from plasma can be helpful for various medical therapies which includes immune deficiencies, autoimmune, bleeding and neurological disorders. By replacing the missing or deficient proteins in plasma, plasma protein therapies can be able to treat life-threatening genetic and chronic diseases.

Rising number of new plasma-derived therapies has increased the demand for the market in the recent years. Rising prevalence of life threatening diseases that involves neurological or immune system and others infectious diseases like Tetanus, Rabies, varicella and Hepatitis A&B are some of the factors enabling the growth of the market. However, there are a few restraints that may prove to be a bottleneck for the growth of the market including stringent regulatory policies, reimbursement issues and manufacturing complexity.  

The North America Plasma Protein Therapeutics Market are categorised by product type as Albumin, Coagulation Factors, Immunoglobulins, alpha-1 proteinase inhibitor and others. The market is also analysed by segmenting it based on application as Primary Immunodeficiency Disorder, Secondary Immunodeficiency, Hemophilia, Idiopathic Thrombocytopenic Purpura and others. On the basis of geography, North American market is segmented into US and Canada.

Investment in research & development of the plasma proteins are boosting the prospect of the North America market. The major players in the plasma protein therapeutic market are                Baxter, Biotest, CSL Behring, Grifols, China Biologics, Shire Plc., Kedrion, Octapharma and Chengdu Inst.

 

1. Introduction                                                                                                 

                1.1 Market Definition                                                                                    

                1.2 Study Deliverables                                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                                          

                1.4 General Study Assumptions                                                                                

2. Research Methodology                                                                                                           

                2.1 Introduction                                                                                               

                2.2 Research Phases                                                                                      

                                2.2.1 Secondary Research                                                                           

                                2.2.2 Primary Research                                                                 

                                2.2.3 Econometric Modelling                                                                      

                                2.2.4 Expert Validation                                                                  

                2.3 Analysis Design                                                                                         

                2.4 Study Timeline                                                                                          

3. Overview                                                                                                       

                3.1 Executive Summary                                                                                

                3.2 Key Inferences                                                                                         

                3.3 New Developments                                                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                                    

                4.1 Market Drivers                                                                                          

                4.2 Market Restraints                                                                                    

                4.3 Key Challenges                                                                                         

                4.4 Current Opportunities in the Market                                                                                              

5. Market Segmentation                                                                                                              

                5.1 By Type                                                                                        

                                5.1.1 Immunoglobulins                                                                 

                                5.1.2 Albumin                                                                   

                                5.1.3 Coagulation Factors                                                                             

                                5.1.4 Alpha-1 proteinase inhibitor                                                                            

                                5.1.5 Others                                                                      

                5.2 By Application                                                                                           

                                5.2.1 Hemophilia                                                                             

                                5.2.2 Primary Immunodeficiency Disorder                                                                           

                                5.2.3 Idiopathic Thrombocytopenic Purpura                                                                        

                                5.2.4 Secondary Immunodeficiency                                                                        

                                5.2.5 Others                                                                      

6. Geographical Analysis                                                                                                              

                6.1 Introduction                                                                                               

                6.2 United States                                                                                            

                6.3 Canada                                                                                         

7. Strategic Analysis                                                                                                       

                7.1 PESTLE analysis                                                                                         

                                7.1.1 Political                                                                     

                                7.1.2 Economic                                                                 

                                7.1.3 Social                                                                         

                                7.1.4 Technological                                                                         

                                7.1.5 Legal                                                                          

                                7.1.6 Environmental                                                                       

                7.2 Porter’s Five analysis                                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                                        

                                7.2.2 Bargaining Power of Consumers                                                                    

                                7.2.3 Threat of New Entrants                                                                     

                                7.2.4 Threat of Substitute Products and Services                                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                                     

8. Market Leaders' Analysis                                                                                                        

                8.1 CSL Behring                                                                

                                8.1.1 Overview                                                                 

                                8.1.2 Product Analysis                                                                   

                                8.1.3 Strategic Evaluation and Operations                                                                            

                                8.1.4 Financial analysis                                                                  

                                8.1.5 Legal issues                                                                             

                                8.1.6 Recent Developments                                                                       

                                8.1.7 SWOT analysis                                                                       

                                8.1.8 Analyst View                                                                          

                8.2 Baxter                                                                           

                8.3 Biotest                                                                          

                8.4 China Biologics                                                                          

                8.5 Grifols                                                                           

                8.6 Kedrion                                                                        

                8.7 Octapharma                                                                               

                8.8 Shire Plc.                                                                      

                8.9 Chengdu Inst.                                                                            

9. Competitive Landscape                                                                                                           

                9.1 Market share analysis                                                                                            

                9.2 Merger and Acquisition Analysis                                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                                         

                9.4 New Product Launches                                                                                         

10. Expert Opinions                                                                                                        

                10.1 Market Outlook                                                                                     

                10.2 Investment Opportunities                                                                                 

Appendix                                                                                                           

                a) List of Tables                                                                                

                b) List of Figures                                                                                              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

TitlePriceAdd To Cart
  1. North America Plasma Protein Therapeutics Market By Type, From 2015-2020 (USD Billion)
  2. North America Plasma Protein Therapeutics Market By Application From 2015-2020 (USD Billion)
  3. North America Immunoglobulins Market By Region, From 2015-2020 (USD Billion)
  4. North America Albumin Market By Region, From 2015-2020 (USD Billion)
  5. North America Coagulation Factors Market By Region, From 2015-2020 (USD Billion)
  6. North America Alpha-1 proteinase inhibitor Market By Region, From 2015-2020 (USD Billion)
  7. North America Others Market By Region, From 2015-2020 (USD Billion)
  8. North America Hemophilia Market By Region, From 2015-2020 (USD Billion)
  9. North America Primary Immunodeficiency Disorder Market By Region, From 2015-2020 (USD Billion)
  10. North America Idiopathic Thrombocytopenic Purpura Market By Region, From 2015-2020 (USD Billion)
  11. North America Secondary Immunodeficiency Market By Region, From 2015-2020 (USD Billion)
  12. North America Others Market By Region, From 2015-2020 (USD Billion)
  13. United States Plasma Protein Therapeutics Market By Type, From 2015-2020 (USD Billion)
  14. Canada Plasma Protein Therapeutics Market By Type, From 2015-2020 (USD Billion)
  15. United States Plasma Protein Therapeutics Market By Application, From 2015-2020 (USD Billion)
  16. Canada Plasma Protein Therapeutics Market By Application, From 2015-2020 (USD Billion)

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, kakatiya's empire,
Jubilee Gardens,
Hyderabad, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.